A review of biodegradable polymeric systems for oral insulin delivery

Abstract

Currently, repeated routine subcutaneous injections of insulin are the standard treatment for insulin-dependent diabetic patients. However, patients’ poor compliance for injections often fails to achieve the stable concentration of blood glucose. As a protein drug, the oral bioavailability of insulin is low due to many physiological reasons. Several carriers, such as macromolecules and liposomes have been used to deliver drugs in vivo. In this review article, the gastrointestinal barriers of oral insulin administration are described. Strategies for increasing the bioavailability of oral insulin, such absorption enhancers, enzyme inhibitors, enteric coatings are also introduced. The potential absorption mechanisms of insulin-loaded nanoparticles across the intestinal epithelium, including intestinal lymphatic route, transcellular route and paracellular route are discussed in this review. Natural polymers, such as chitosan and its derivates, alginate derivatives, γ-PGA-based materials and starch-based nanoparticles have been exploited for oral insulin delivery; synthetic polymers, such as PLGA, PLA, PCL and PEA have also been developed for oral administration of insulin. This review focuses on recent advances in using biodegradable natural and synthetic polymers for oral insulin delivery along with their future prospects.

• Bioavailability
• biodegradable
• insulin
• oral delivery
• polymer

Declaration of interest

The authors would like to acknowledge the financial support from the National Natural Science Foundation of China (No. 21264009 and 31360376), the Natural Science Foundation of Jiangxi Province (No. 20132BAB206034), the Scientific and Technological Landing Project of Higher Education of Jiangxi Province (No. KJLD13071) and the Cultivation Project for Academic and Technical Leaders of Major Disciplines of Jiangxi Province.